Artiva Biotherapeutics (ARTV) Cash From Investing

Annual CFI

-$25.98 M
-$19.68 M-312.37%

December 1, 2023


Summary


Performance

ARTV Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherARTVcash flowmetrics:

Quarterly CFI

-$130.63 M
-$131.98 M-9783.32%

September 1, 2024


Summary


Performance

ARTV Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherARTVcash flowmetrics:

TTM CFI

-$122.17 M
-$130.13 M-1632.81%

September 1, 2024


Summary


Performance

ARTV TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherARTVcash flowmetrics:

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

ARTV Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-312.4%-10000.0%-424.2%
3 y3 years-9046.1%-523.5%-435.5%
5 y5 years--523.5%-435.5%

ARTV Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-1406.7%at low-1435.4%at low-1632.8%at low
5 y5-year-9046.1%at low-1435.4%at low-1632.8%at low
alltimeall time-9046.1%at low-1435.4%at low-1632.8%at low

Artiva Biotherapeutics Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
-$130.63 M(-9783.3%)
-$122.17 M(-1632.8%)
Jun 2024
-
$1.35 M(-86.2%)
$7.97 M(-155.6%)
Mar 2024
-
$9.78 M(-466.6%)
-$14.33 M(-44.8%)
Dec 2023
-$25.98 M
-$2.67 M(+441.2%)
-$25.98 M(+11.4%)
Sep 2023
-
-$493.00 K(-97.6%)
-$23.31 M(+2.2%)
Jun 2023
-
-$20.95 M(+1025.2%)
-$22.81 M(+1125.2%)
DateAnnualQuarterlyTTM
Mar 2023
-
-$1.86 M(+209.3%)
-$1.86 M(+209.3%)
Dec 2022
-$6.30 M(+265.4%)
-
-
Mar 2022
-
-$602.00 K(+1208.7%)
-$602.00 K(+1208.7%)
Dec 2021
-$1.72 M(+507.0%)
-
-
Mar 2021
-
-$46.00 K
-$46.00 K
Dec 2020
-$284.00 K
-
-

FAQ

  • What is Artiva Biotherapeutics annual cash flow from investing activities?
  • What is the all time high annual CFI for Artiva Biotherapeutics?
  • What is Artiva Biotherapeutics annual CFI year-on-year change?
  • What is Artiva Biotherapeutics quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Artiva Biotherapeutics?
  • What is Artiva Biotherapeutics quarterly CFI year-on-year change?
  • What is Artiva Biotherapeutics TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Artiva Biotherapeutics?
  • What is Artiva Biotherapeutics TTM CFI year-on-year change?

What is Artiva Biotherapeutics annual cash flow from investing activities?

The current annual CFI of ARTV is -$25.98 M

What is the all time high annual CFI for Artiva Biotherapeutics?

Artiva Biotherapeutics all-time high annual cash flow from investing activities is -$284.00 K

What is Artiva Biotherapeutics annual CFI year-on-year change?

Over the past year, ARTV annual cash flow from investing activities has changed by -$19.68 M (-312.37%)

What is Artiva Biotherapeutics quarterly cash flow from investing activities?

The current quarterly CFI of ARTV is -$130.63 M

What is the all time high quarterly CFI for Artiva Biotherapeutics?

Artiva Biotherapeutics all-time high quarterly cash flow from investing activities is $9.78 M

What is Artiva Biotherapeutics quarterly CFI year-on-year change?

Over the past year, ARTV quarterly cash flow from investing activities has changed by -$130.13 M (-26396.55%)

What is Artiva Biotherapeutics TTM cash flow from investing activities?

The current TTM CFI of ARTV is -$122.17 M

What is the all time high TTM CFI for Artiva Biotherapeutics?

Artiva Biotherapeutics all-time high TTM cash flow from investing activities is $7.97 M

What is Artiva Biotherapeutics TTM CFI year-on-year change?

Over the past year, ARTV TTM cash flow from investing activities has changed by -$98.86 M (-424.16%)